Atlas Venture Fund Xii, L.P. is of Vigil Neuroscience, Inc.. Currently has a direct ownership of 0 shares of VIGL, which is worth approximately $0. The most recent transaction as insider was on Aug 05, 2025, when has been sold 4,808,896 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

Atlas Venture Fund XII, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 05 2025
SELL
Sale (or disposition) back to the issuer
-
4,808,896 Reduced 100.0%
0 Common Stock

Also insider at

AVTE
Aerovate Therapeutics, Inc. Healthcare
AVF

Atlas Venture Fund Xii, L.P.

Cambridge, MA

Track Institutional and Insider Activities on VIGL

Follow Vigil Neuroscience, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIGL shares.

Notify only if

Insider Trading

Get notified when an Vigil Neuroscience, Inc. insider buys or sells VIGL shares.

Notify only if

News

Receive news related to Vigil Neuroscience, Inc.

Track Activities on VIGL